Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer

The use of of CDK4/6 inhibitors to treat patients with TNBC is limited by loss of Rb. Here, the authors show that a combination of CDK4/6 inhibitor and EGFR inhibitor is effective against DEDD-overexpressing TNBC, independent of Rb status.

Guardado en:
Detalles Bibliográficos
Autores principales: Yingjia Ni, Keon R. Schmidt, Barnes A. Werner, Jenna K. Koenig, Ian H. Guldner, Patricia M. Schnepp, Xuejuan Tan, Lan Jiang, Misha Host, Longhua Sun, Erin N. Howe, Junmin Wu, Laurie E. Littlepage, Harikrishna Nakshatri, Siyuan Zhang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/6cd4e5da2a3943ceb86081cf1bcee7ae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/6cd4e5da2a3943ceb86081cf1bcee7ae

Ejemplares similares